Mark S. Ordan Sells 22,166 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) Stock

Pediatrix Medical Group, Inc. (NYSE:MDGet Rating) CEO Mark S. Ordan sold 22,166 shares of the company’s stock in a transaction on Monday, November 21st. The stock was sold at an average price of $15.45, for a total transaction of $342,464.70. Following the sale, the chief executive officer now directly owns 346,645 shares in the company, valued at $5,355,665.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Pediatrix Medical Group Trading Up 1.5 %

MD stock opened at $15.81 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.20. The company’s 50-day simple moving average is $17.00 and its 200 day simple moving average is $19.03. Pediatrix Medical Group, Inc. has a 52 week low of $14.48 and a 52 week high of $28.02. The company has a market capitalization of $1.31 billion, a PE ratio of 15.97, a price-to-earnings-growth ratio of 1.12 and a beta of 1.83.

Analysts Set New Price Targets

Several research firms have issued reports on MD. StockNews.com lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 20th. SVB Leerink dropped their price objective on shares of Pediatrix Medical Group from $20.00 to $16.00 and set a “market perform” rating on the stock in a research report on Friday, November 4th. William Blair reissued an “outperform” rating on shares of Pediatrix Medical Group in a research report on Thursday, November 3rd. Credit Suisse Group dropped their price objective on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a research report on Thursday, August 11th. Finally, BMO Capital Markets dropped their price objective on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a “market perform” rating on the stock in a research report on Wednesday, August 10th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $20.00.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of Pediatrix Medical Group by 2.3% in the first quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock valued at $224,045,000 after acquiring an additional 212,150 shares in the last quarter. State Street Corp grew its stake in Pediatrix Medical Group by 2.2% during the third quarter. State Street Corp now owns 3,373,969 shares of the company’s stock worth $55,704,000 after buying an additional 72,731 shares in the last quarter. Lazard Asset Management LLC grew its stake in Pediatrix Medical Group by 24.3% during the first quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock worth $76,631,000 after buying an additional 637,798 shares in the last quarter. River Road Asset Management LLC grew its stake in Pediatrix Medical Group by 98.3% during the first quarter. River Road Asset Management LLC now owns 2,607,218 shares of the company’s stock worth $61,217,000 after buying an additional 1,292,605 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in Pediatrix Medical Group by 5.0% during the first quarter. Wellington Management Group LLP now owns 1,857,926 shares of the company’s stock worth $43,624,000 after buying an additional 88,359 shares in the last quarter. 95.98% of the stock is currently owned by institutional investors and hedge funds.

About Pediatrix Medical Group

(Get Rating)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Read More

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.